A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Ferreri, Kevin, Ph.D. Bookmark and Share

Ferreri, Kevin Ph.D. Research

Islet Cell Biology
Islet cell therapy is a very promising treatment for type 1 diabetes, but suffers from variability in the cell preparations used for transplantation. As part of this clinical program, my group has developed several new approaches for islet cell characterization, including metabolic parameters and gene expression profiling for evaluation of the islet cells prior to transplantation. Glucose stimulates insulin secretion from islets, and we are quantifying this response by the oxygen consumption rate and changes in cytochrome reduction. We have shown that these parameters have a high correlation with the ability of islets to reverse diabetes, and therefore identify “good” islet preparations. In a parallel study, we completed the gene expression profiling of several islet preparations and have identified a “gene signature” of islet quality. This geneset accurately predicts in vivo efficacy of transplanted islets, and we are developing a diagnostic test for islet function. We are also exploring the functional roles of these genes, which should lead to a better understanding of islet biology and better treatments for diabetics.
 
Circulating Nucleic Acids
A major difficult in both islet transplantation therapy and in diabetes in general is the lack of diagnostic tests that can be used to monitor islets in vivo. Based on the hypothesis that dying islet cells release cell debris into circulation, my group is measuring specific nucleic acids in the blood of our islet recipients and new onset diabetic patients. We have developed a highly sensitive and specific method to detect DNA from transplanted islets in the recipient’s circulation and find that the levels correlate with damage to the islet grafts. Recently we developed a similar test based on a unique DNA pattern we discovered for early detection of type 1 diabetes. These early markers of islet injury will allow timely intervention to prevent further loss of islet cells. We are building on these approaches to develop biomarkers for type 2 diabetes and diabetic complications.
 

Kevin Ferreri, Ph.D., Lab Members

Kevin Ferreri, Ph.D.
Associate Research Professor
626-256-HOPE (4673) ext.  65021
 
Mohamed El-Sayed, Ph.D.
Staff Scientist
626-256-HOPE (4673) ext.  31247
 
Alexander Kaye
Research Associate I
626-256-HOPE (4673) ext.  31218
 

Ferreri, Kevin, Ph.D.

Ferreri, Kevin Ph.D. Research

Islet Cell Biology
Islet cell therapy is a very promising treatment for type 1 diabetes, but suffers from variability in the cell preparations used for transplantation. As part of this clinical program, my group has developed several new approaches for islet cell characterization, including metabolic parameters and gene expression profiling for evaluation of the islet cells prior to transplantation. Glucose stimulates insulin secretion from islets, and we are quantifying this response by the oxygen consumption rate and changes in cytochrome reduction. We have shown that these parameters have a high correlation with the ability of islets to reverse diabetes, and therefore identify “good” islet preparations. In a parallel study, we completed the gene expression profiling of several islet preparations and have identified a “gene signature” of islet quality. This geneset accurately predicts in vivo efficacy of transplanted islets, and we are developing a diagnostic test for islet function. We are also exploring the functional roles of these genes, which should lead to a better understanding of islet biology and better treatments for diabetics.
 
Circulating Nucleic Acids
A major difficult in both islet transplantation therapy and in diabetes in general is the lack of diagnostic tests that can be used to monitor islets in vivo. Based on the hypothesis that dying islet cells release cell debris into circulation, my group is measuring specific nucleic acids in the blood of our islet recipients and new onset diabetic patients. We have developed a highly sensitive and specific method to detect DNA from transplanted islets in the recipient’s circulation and find that the levels correlate with damage to the islet grafts. Recently we developed a similar test based on a unique DNA pattern we discovered for early detection of type 1 diabetes. These early markers of islet injury will allow timely intervention to prevent further loss of islet cells. We are building on these approaches to develop biomarkers for type 2 diabetes and diabetic complications.
 

Lab Members

Kevin Ferreri, Ph.D., Lab Members

Kevin Ferreri, Ph.D.
Associate Research Professor
626-256-HOPE (4673) ext.  65021
 
Mohamed El-Sayed, Ph.D.
Staff Scientist
626-256-HOPE (4673) ext.  31247
 
Alexander Kaye
Research Associate I
626-256-HOPE (4673) ext.  31218
 
Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.
 

Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Develop new therapies, diagnostics and preventions in the fight against cancer and other life-threatening diseases.
 
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 


NEWS & UPDATES
  • Cancer treatments have improved over the years, but one potential source of treatments and cures remains largely untapped: nature. Blueberries, cinnamon, xinfeng, grape seed (and skin) extract, mushrooms, barberry and pomegranates all contain compounds with the potential to treat or prevent cancer. Scientists a...
  • In the U.S., there are more new cases of skin cancer than the combined incidence of cancers of the breast, prostate and lung, according to the American Cancer Society. Each year, 5 million people are treated for skin cancer. Here, Hans Schoellhammer, M.D., assistant clinical professor at City of Hope | Ant...
  • As public health experts know, health improvement starts in the community. Now, City of Hope  has been recognized for its efforts to improve the lives of residents of its own community. The institution will receive funding from the Institute for Healthcare Improvement  to support promising community-based work ...
  • For almost four decades, blood cancer survivors who received bone marrow, or stem cell, transplants have returned to City of Hope to celebrate life, second chances and science. The first reunion, in 1976, was a small affair: spaghetti for a single patient, his brother who served as his donor and those who took ...
  • Chemotherapy is an often-essential component of cancer treatment, attacking cells that divide quickly and helping stop cancer’s advance. But the very characteristics that make chemotherapy effective against cancer also can make it toxic to healthy cells, leading to side effects such as hair loss, nausea, ...
  • When you want to understand how to enhance the patient experience, go straight to the source: The patients. Patients and their families offer unique perspectives on care and services and can provide valuable insights about what is working well and what is not. That’s why City of Hope turns to them for advice. S...
  • Take it from City of Hope researchers: Medical science isn’t just for scientists, but something the whole family can enjoy. From 1 to 4 p.m. on Saturday, May 16, the institution will offer a variety of educational and fun-filled science and healthy living activities at its second Community Science Festiva...
  • Attention, parents! Only a few serious sunburns can increase a child’s ultimate risk of skin cancer. Further, some studies suggest that ultraviolet (UV) exposure before the age of 10 is the most important factor for melanoma risk. Here skin cancer expert Jae Jung, M.D., Ph.D., assistant professor in the D...
  • Esophagheal cancer may not be on many people’s radar, but heartburn probably is. The latter can ultimately lead to the former. More formally referred to as gastroesophageal reflux, heartburn occurs when stomach content makes its way back up into the esophagus, causing stomach acid to come into contact with the ...
  • Many City of Hope cancer patients are opening their hearts to an electronic confidante. The tablet-based program, called SupportScreen, prompts them to share deeply personal concerns about their health — and helps jump-start their care. “We’ve found that people will reveal more to a machine than to a person. Te...
  • Older adults, by far, represent the largest population of cancer patients globally. With the median age of U.S. citizens projected to increase sharply in the next few years, the incidence of cancer is expected to rise higher, as well. City of Hope is at the forefront of geriatric cancer care, and an important n...
  • Treatment of cancers of the head and neck requires not just skill, but consummate skill. After all, consider their location: the lip, mouth, tongue, throat and nasal cavity – and that’s just for starters. Such treatment can include chemotherapy and radiation, but surgery is often the primary approach, wit...
  • On a spring day in 2013, 10-year-old Jackie Garcia of Whittier, California, noticed a lump in her jaw. Her mother suspected it was a minor problem, perhaps due to a fall, but made an appointment with a pediatrician, just to be on the safe side. “He thought it was an infection that was dental-related, and told [...
  • Creative expression comes in two very different forms for Robert Kang, M.D., M.P.H., assistant clinical professor of otolaryngology and a plastic surgeon at City of Hope. In his day job, Kang performs surgeries on patients with complex head and neck cancers, specializing in advanced facial reconstructions and r...
  • Surgery for head and neck cancers is unarguably complex, requiring extremely controlled movements and exceptional training. “Given where we are operating, our primary concern is maintaining speaking, swallowing and breathing,” said Ellie Maghami, M.D., chief of head and neck surgery, who recently teamed with Ro...